May 3, 2025
PCSK9 Inhibitors in 2025: Costs, Convenience, and Cardiovascular Benefits Reviewed
Complex generic drugs face major scientific and regulatory hurdles that make approval far harder than for simple generics. Despite high demand and patent expirations, few reach the market due to technical challenges, unclear FDA guidance, and high development costs.
